The Supreme Court ruled unanimously on Thursday, June 13th, that Myriad Genomics Inc. may not retain exclusive rights to the use of DNA sequence information for breast cancer associated genes BRCA1 and BRCA2, stating that Myriad had not created anything new in identifying the genes.
Read More
Last week, a cicada-like re-emergence of “Bell Curve” claims of a genetic determinacy between intelligence and race surfaced in a Heritage Foundation special report on immigration. The report drew on Jason Richwine’s Harvard dissertation, “IQ and Immigration Policy.” Amid the furor, the Atlantic’s Ta Nehisi Coates was ready with the history. He wrote in response to Richwine’s apologists, who…
Read More The Supreme Court ruled unanimously on Thursday, June 13th, that Myriad Genomics Inc. may not retain exclusive rights to the use of DNA sequence information for breast cancer associated genes BRCA1 and BRCA2, stating that Myriad had not created anything new in identifying the genes.
Last week, a cicada-like re-emergence of “Bell Curve” claims of a genetic determinacy between intelligence and race surfaced in a Heritage Foundation special report on immigration. The report drew on Jason Richwine’s Harvard dissertation, “IQ and Immigration Policy.” Amid the furor, the Atlantic’s Ta Nehisi Coates was ready with the history. He wrote in response to Richwine’s apologists, who…